Abbey Clinical Pathology Limited - Limited company - abbreviated

ABBEY CLINICAL PATHOLOGY LIMITED

ABBREVIATED UNAUDITED ACCOUNTS

FOR THE YEAR ENDED 30 APRIL 2015

Page

Company Information

1

Abbreviated Balance Sheet

2

Notes to the Abbreviated Accounts

3

DIRECTORS:

S W Steen

T Whitbread

Mrs R Whitbread

SECRETARY:

REGISTERED OFFICE:

Lowlands

16 The Village

Keele

Newcastle

Staffordshire

ST5 5AR

REGISTERED NUMBER:

07239872 (England and Wales)

ACCOUNTANTS:

Barretts

Chartered Accountants &

Chartered Tax Advisers

22 Union Street

Newton Abbot

Devon

TQ12 2JS

FIXED ASSETS

Tangible assets

2

-

2,791

CURRENT ASSETS

Stocks

-

368

Debtors

-

59,837

Cash at bank

67,253

22,527

67,253

82,732

CREDITORS

Amounts falling due within one year

7,721

14,643

NET CURRENT ASSETS

59,532

68,089

TOTAL ASSETS LESS CURRENT
LIABILITIES

59,532

70,880

PROVISIONS FOR LIABILITIES

-

558

NET ASSETS

59,532

70,322

CAPITAL AND RESERVES

Called up share capital

3

100

Profit and loss account

59,432

70,222

SHAREHOLDERS' FUNDS

59,532

70,322

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2015.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2015 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.

The financial statements were approved by the Board of Directors on 26 October 2015 and were signed on its behalf by:

T Whitbread - Director

1.	ACCOUNTING POLICIES

Accounting convention

The financial statements have been prepared under the historical cost convention and in accordance with the

Financial Reporting Standard for Smaller Entities (effective April 2008).

Turnover

Turnover represents net invoiced sales of goods, excluding value added tax.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

25% on reducing balance

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow

moving items.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance

sheet date.

2.	TANGIBLE FIXED ASSETS

Total

£

COST

At 1 May 2014

8,321

Disposals

(8,321

)

At 30 April 2015

-

DEPRECIATION

At 1 May 2014

5,530

Eliminated on disposal

(5,530

)

At 30 April 2015

-

NET BOOK VALUE

At 30 April 2015

-

At 30 April 2014

2,791

3.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2015

2014

value:

£

35

Ordinary A

1

35

Ordinary B

1

35

30

Ordinary C

1

30

100

4.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

At the balance sheet date the company owed the following amounts to the directors:

Mr & Mrs Whitbread £7431 (2014 - £7431)

Mr Steen £290 (2014 - £290)

Abbey Clinical Pathology Limited - Limited company - abbreviated - 11.6

Abbey Clinical Pathology Limited - Limited company - abbreviated - 11.6